Search
Medicus Pharma Ltd
MDCXAdd to Watchlist
0.458USD
+0.106+30.08%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
18.30MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
3
analysts
Buy
Current Rating
5.667
Target Price
+1511.22%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
Medicus Pharma Ltd
MDCX
3
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Medicus Pharma Ltd's price target?
Analysts forecast that Medicus Pharma Ltd's price target is USD 20.00, with the highest forecast at USD 27.00 and the lowest forecast at USD 20.00.
How have Medicus Pharma LtdMDCX's recent earnings per share performed?
The market expectation was USD -0.31, while Medicus Pharma LtdMDCX's earnings per share (EPS) for the previous quarter was USD -0.81. EPS for the next quarter is expected at USD -0.13.
What is the analyst rating for Medicus Pharma Ltd?
Based on the ratings of Medicus Pharma Ltd's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
